Long-Term Stability of a Portable Carbon Monoxide Single-Breath Diffusing Capacity Instrument

References

1. 1.↵
   1. Pellegrino R,
   2. Viegi G,
   3. Brusasco V,
   4. Crapo RO,
   5. Burgos F,
   6. Casaburi R,
   7. et al

   . Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948–968.

   OpenUrlFREE Full Text
2. 2.↵
   1. Wanger J,
   2. Irvin C

   . Comparability of pulmonary function results from 13 laboratories in a metropolitan area. Respir Care 1991;36(12):1375–1382.

   OpenUrlPubMed
3. 3.↵
   1. Borg BM,
   2. Hartley MF,
   3. Bailey MJ,
   4. Thompson BR

   . Adherence to acceptability and repeatability criteria for spirometry in complex lung function laboratories. Respir Care 2012;57(12):2032–2038.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Gochicoa-Rangel L,
   2. Torre-Bouscoulet L,
   3. Martínez-Briseño D,
   4. Rodríguez-Moreno L,
   5. Cantú-González G,
   6. Vargas MH

   . Values of impulse oscillometry in healthy Mexican children and adolescents. Respir Care 2015;60(1):119–127.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Gochicoa-Rangel L,
   2. Vargas-Domínguez C,
   3. García-Mujica ME,
   4. Bautista-Bernal A,
   5. Salas-Escamilla I,
   6. Pérez-Padilla R,
   7. Torre-Bouscoulet L

   . Quality of spirometry in 5-to-8-year-old children. Pediatr Pulmonol 2013;48(12):1231–1236.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Gallo HM,
   2. Crapo RO,
   3. Jensen RL

   . Monitoring carbon monoxide diffusing capacity devices with a simulator. J Investig Med 2007;55(1):S153.

   OpenUrlAbstract/FREE Full Text
7. 7.
   1. Miller MR,
   2. Hankinson J,
   3. Brusasco V,
   4. Burgos F,
   5. Casaburi R,
   6. Coates A,
   7. et al

   . Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Macintyre N,
   2. Crapo RO,
   3. Viegi G,
   4. Johnson DC,
   5. van der Grinten CP,
   6. Brusasco V,
   7. et al

   . Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26(4):720–735.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Pérez-Padilla R,
   2. Valdivia G,
   3. Muiño A,
   4. López MaV,
   5. Márquez MaN,
   6. Montes-de-Oca Ma,
   7. et al

   . Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad. Arch Bronchoneumol 2006;42(7):317–325.

   OpenUrl
10. 10.↵
    1. Crapo RO,
    2. Morris AH

    . Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981;123(2):185–189.

    OpenUrlPubMedWeb of Science
11. 11.↵
    1. Neas LM,
    2. Schwartz J

    . The determinants of pulmonary diffusing capacity in a national sample of U.S. adults. Am J Respir Crit Care Med 1996;153(2):656–664.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Haynes JM

    . Comprehensive quality control for pulmonary function testing: it's time to face the music. Respir Care 2010;55(3):355–357.

    OpenUrlFREE Full Text
13. 13.↵
    1. Punjabi NM,
    2. Shade D,
    3. Patel AM,
    4. Wise RA

    . Measurement variability in single-breath diffusing capacity of the lung. Chest 2003;123(4):1082–1089.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Hegewald MJ,
    2. Markewitz BA,
    3. Wilson EL,
    4. Gallo HM,
    5. Jensen RL

    . Single-breath diffusing capacity for carbon monoxide instrument accuracy across 3 health systems. Respir Care 2015;60(3):430–436.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Wise RA,
    2. Teeter JG,
    3. Jensen RL,
    4. England RD,
    5. Schwartz PF,
    6. Giles DR,
    7. et al

    . Standardization of the single-breath diffusing capacity in a multicenter clinical trial. Chest 2007;132(4):1191–1197.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Jensen R,
    2. Leyk M,
    3. Crapo R,
    4. Muchmore D,
    5. Berclaz PY

    . Quality control of D_LCO instruments in global clinical trials. Eur Respir J 2009;33(4):828–834.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Jensen R,
    2. Make B,
    3. Regan E,
    4. Silverman E,
    5. Crapo J

    . COPDGene intra-subject variability of D_LCO measurements using an ultrasound-based instrument. Eur Respir J 2015;46(Suppl 59):PA1028.

    OpenUrl
18. 18.↵
    1. Moore OA,
    2. Proudman SM,
    3. Goh N,
    4. Corte TJ,
    5. Rouse H,
    6. Hennessy O,
    7. et al

    . Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clin Exp Rheumatol 2015;33(4 Suppl 91):S111–S116.

    OpenUrl
19. 19.
    1. Novelli F,
    2. Tavanti L,
    3. Cini S,
    4. Aquilini F,
    5. Melosini L,
    6. Romei C,
    7. et al

    . Determinants of the prognosis of idiopathic pulmonary fibrosis. Eur Rev Med Pharmacol Sci 2014;18(6):880–886.

    OpenUrl
20. 20.
    1. Raghu G,
    2. Collard HR,
    3. Egan JJ,
    4. Martinez FJ,
    5. Behr J,
    6. Brown KK,
    7. et al

    . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183(6):788–824.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.
    1. Miguel-Reyes JL,
    2. Gochicoa-Rangel L,
    3. Pérez-Padilla R,
    4. Torre-Bouscoulet L

    . Functional respiratory assessment in interstitial lung disease. Rev Invest Clin 2015;67(1):5–14.

    OpenUrl
22. 22.↵
    1. Selman M,
    2. Undurraga A,
    3. Buendía-Roldán I,
    4. Caro-Fabián M,
    5. Curbelo P,
    6. Mejía M,
    7. et al

    . Recomendaciones para el diagnóstico y tratamiento de la fibrosis pulmonar idiopática. Respirar. https://www.alatorax.org/formacion-profesional/respirar-newsletter-alat/recomendaciones-para-el-diagnostico-y-tratamiento-de-la-fibrosis-pulmonar-idiopatica-2015. Accessed August 18, 2016.